CSL LTD SPON ADR EACH REPR 0.5 ORD News

Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia Teens

Yahoo FinanceMay 1 00:19

ARS Pharmaceuticals Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's CHMP and Enters License Agreement With CSL Seqirus for Commercialization of Neffy in Australia and New Zealand

Yahoo FinanceApr 30 21:01

FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia

Friday, the FDA approved Pfizer Inc's (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis therapy or h

BenzingaApr 27 02:30

Travere, CSL Win Conditional Nod for Kidney Disease Therapy in EU

Seeking AlphaApr 24 20:31

CureVac Posts Early Efficacy Results for GSK-partnered Flu Shot

Seeking AlphaApr 4 20:20

Akebia Stock Jumps as FDA Clears Renal Anemia Therapy

Seeking AlphaMar 28 17:42

Kyowa Kirin's Rare Disease Therapy Becomes World's Most Expensive Drug

Seeking AlphaMar 21 00:11

Ferinject Approved by Health Canada for the Treatment of Iron Deficiency Anemia in Adult...

Stockhouse Mar 19 19:00

CSL Ltd's Dividend Analysis

Yahoo FinanceMar 11 19:01

CSL Goes Ex Dividend Tomorrow

Seeking AlphaMar 7 22:19

'Tripledemic' Burden Lower This Winter Despite COVID Impact: Airfinity

Seeking AlphaFeb 28 02:44

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy

Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) in Europe Positive CHMP opinion is

GlobeNewswireFeb 23 20:05

Travere Therapeutics Gains as EU Backs Kidney Disease Therapy

Seeking AlphaFeb 23 20:05

CSL LTD SPON ADR EACH REPR 0.5 ORD To Go Ex-Dividend On March 11th, 2024 With 0.595 USD Dividend Per Share

February 15th - $CSL LTD SPON ADR EACH REPR 0.5 ORD(CSLLY.US)$ is trading ex-dividend on March 11th, 2024. Shareholders of record on March 12th, 2024 will receive 0.595 USD dividend per share. The

Futu NewsFeb 15 08:40

Earnings Call Summary | CSL LTD SPON ADR EACH REPR 0.5 ORD(CSLLY.US) Q2 2024 Earnings Conference

The following is a summary of the CSL Ltd (CSLLY) Q2 2024 Earnings Call Transcript:Financial Performance:CSL reported revenue of $8.1 billion, an increase of 11% at constant currency.CSL's NPATA was $

Futu NewsFeb 13 14:08 · Conference Call

CSL Limited Falls After Phase 3 Setback for Key Trial

Seeking AlphaFeb 13 02:53

CSL Announces Top-line Results From the Phase 3 AEGIS-II Trial Evaluating the Efficacy and Safety...

Stockhouse Feb 12 06:47

Masking Returns to Some U.S. Hospitals Amid Rising COVID, Flu Cases

Seeking AlphaJan 5 02:51

Pfizer Wins Canada Approval for Hemophilia B Gene Therapy

Seeking AlphaJan 3 23:19

CSL and Arcturus Therapeutics' ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation MRNA Vaccine Booster

Data follow approval of the world's first Self-Amplifying messenger RNA (sa-mRNA) COVID-19 Vaccine for Adults by Japan Ministry of Health, Labor and Welfare.

Arcturus TherapeuticsDec 21, 2023 21:00